Development of Allogeneic NK Cell Therapeutics Using T Cell-based Feeder System

Time: 9:00 am
day: Day One


  • Outlining an engineered T cell as a new feeder system for NK cell activation and expansion
  • Discussing characteristics of NK cell expansion profile using e-Feeder system
  • Covering clinical trials of expanded, activated allogeneic
  • NK cells by large-scale production
  • Development of gene-modified NK cell
  • Discussing technical issues for CAR-NKs